Approvals/TGA/ATROVENT NASAL FORTE ipratropium bromide monohydrate 44 microgram/actuation spray solution

Approved

STANDARD

ATROVENT NASAL FORTE ipratropium bromide monohydrate 44 microgram/actuation spray solution

Approval Id: 005657ff49db3eef
Product Name: ATROVENT NASAL FORTE ipratropium bromide monohydrate 44 microgram/actuation spray solution
Artg Id: 67490
Artg Name: ATROVENT NASAL FORTE ipratropium bromide monohydrate 44 microgram/actuation spray solution
Sponsor: Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
Company Detail Path: /organization/sanofi-aventis-healthcare-pty-ltd
Artg Date: 1999-05-25
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-CMI-01305-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

005657ff49db3eef

Type

Standard